News

When the FDA declared the shortage resolved for semaglutide, the main pharmaceutical ingredient in Wegovy and Ozempic, the agency gave 503B facilities until May 22 to stop making compounded versions.
You can get in touch with Joe by emailing joe.edwards ... are critical to maintaining the safety effectiveness of semaglutide, Wegovy's active ingredient. Exposure to temperatures outside ...
PHOENIX - Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these ...
Earlier this year, the Danish pharma traded barbs with telehealth provider Hims & Hers over the latter’s practice of selling compounded versions of semaglutide, the drug better known as Novo’s ...
Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA approved for this use. Both drugs are approved for ...
With the end of the shortage of Wegovy and Ozempic, no patient should have to be exposed to unsafe, inauthentic semaglutide drugs." Two weeks ago, Lilly sued an Indianapolis spa, Premier Weight ...
A federal judge April 24 rejected a bid by compounding pharmacies to continue selling less expensive copies of semaglutide, Novo Nordisk's blockbuster drug sold under the brands Wegovy and Ozempic.
“With the end of the shortage of Wegovy and Ozempic, no patient should have to be exposed to unsafe, inauthentic ‘semaglutide’ drugs,” Benz added. The ruling also addresses growing ...
With the end of the shortage of Wegovy and Ozempic, no patient should have to be exposed to unsafe, inauthentic ‘semaglutide’ drugs. “Patient safety remains a top priority for Novo Nordisk ...
blockbuster weight loss drug Wegovy. The San Francisco-based company will begin offering the prescription semaglutide on its platform later this week, with a price point starting at $599.
Sublingual administration offers a potential alternative to both the approved injectable semaglutide (Ozempic and Wegovy) and the oral form (Rybelsus), providing a non-invasive route that allows ...